cyclosporine has been researched along with Experimental Leukemia in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (85.71) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Atassi, G; Dhainaut, A; Guilbaud, N; Kraus-Berthier, L; Leonce, S; Pierre, A; Regnier, G; Tizot, A | 1 |
| Bachireddy, P; Braunstein, L; Crosby, E; Fan, AC; Felsher, DW; Kopelman, A; Rakhra, K; Ryeom, S; Xu, L; Yang, Q; Zabuawala, T; Zeiser, R | 1 |
| Bertrand, R; Jenkins, J; Pommier, Y; Solary, E | 1 |
| Brandt, I; Bunge, A; Dietel, M; Heidebrecht, HJ; Herzig, I; Reymann, A; Schaefer, B; Seidel, A | 1 |
| Björkholm, M; Gruber, A; Larsson, R; Nygren, P; Peterson, C | 1 |
| Blume, KG; Chao, NJ; Kühl, JS; Sikic, BI | 1 |
| Agah, R; Charak, BS; Mazumder, A | 1 |
7 other study(ies) available for cyclosporine and Experimental Leukemia
| Article | Year |
|---|---|
New purines and purine analogs as modulators of multidrug resistance.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channels; Doxorubicin; Drug Resistance, Multiple; Female; Leukemia P388; Leukemia, Experimental; Mice; Molecular Structure; Neoplasm Transplantation; Piperidines; Purines; Structure-Activity Relationship; Triazines; Tumor Cells, Cultured; Vincristine | 1996 |
CD4(+) T cells contribute to the remodeling of the microenvironment required for sustained tumor regression upon oncogene inactivation.
Topics: Animals; Apoptosis; CD4-Positive T-Lymphocytes; Cell Proliferation; Cellular Senescence; Chemokines; Cyclosporine; Fusion Proteins, bcr-abl; Gene Expression Regulation, Neoplastic; Gene Silencing; Immunosuppressive Agents; Leukemia, Experimental; Mice; Mice, Transgenic; Neoplasms; Neovascularization, Pathologic; Oncogenes; Proto-Oncogene Proteins c-myc; Remission Induction; Thrombospondin 1; Tumor Microenvironment | 2010 |
Apoptosis and its modulation in human promyelocytic HL-60 cells treated with DNA topoisomerase I and II inhibitors.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Alkaloids; Aminoquinolines; Aphidicolin; Apoptosis; Benzamides; Calcium; Calmodulin; Camptothecin; Cell Cycle; Chromatin; Cyclosporine; DNA; Egtazic Acid; Ethers, Cyclic; Humans; Isoquinolines; Leukemia, Experimental; Leukemia, Promyelocytic, Acute; Microscopy, Electron; Naphthalenes; Okadaic Acid; Phosphoprotein Phosphatases; Piperazines; Poly Adenosine Diphosphate Ribose; Poly(ADP-ribose) Polymerase Inhibitors; Polycyclic Compounds; Protein Kinase C; Spermine; Staurosporine; Teniposide; Tetradecanoylphorbol Acetate; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Zinc | 1993 |
Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Carrier Proteins; Clone Cells; Cyclosporine; Doxorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Drug Therapy, Combination; Friend murine leukemia virus; Immunohistochemistry; Leukemia, Experimental; Membrane Glycoproteins; Mice; Neoplasm Proteins; Tumor Cells, Cultured | 1994 |
A non-P-glycoprotein-mediated mechanism of vincristine transport which is affected by resistance modifiers and present in chemosensitive cells.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Carrier Proteins; Cell Survival; Cells, Cultured; Cyclosporine; Daunorubicin; Drug Interactions; Drug Resistance; Drug Screening Assays, Antitumor; Gene Expression; Heart; Humans; Leukemia, Experimental; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Membrane Glycoproteins; Myocardium; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured; Verapamil; Vincristine | 1994 |
Use of etoposide in combination with cyclosporin for purging multidrug-resistant leukemic cells from bone marrow in a mouse model.
Topics: Animals; Bone Marrow; Bone Marrow Purging; Cyclosporine; Disease Models, Animal; Drug Combinations; Drug Resistance; Drug Therapy, Combination; Etoposide; Leukemia, Experimental; Male; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Tumor Cells, Cultured | 1992 |
Synergism of interleukin-2 and cyclosporine A in induction of a graft-versus-tumor effect without graft-versus-host disease after syngeneic bone marrow transplantation.
Topics: Animals; Bone Marrow Transplantation; Cyclosporine; Cytotoxicity, Immunologic; Drug Synergism; Graft vs Host Disease; Histocompatibility Antigens Class II; Immunization, Passive; Immunotherapy; Interferon-gamma; Interleukin-2; Killer Cells, Lymphokine-Activated; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Neoplasms, Experimental; Recombinant Proteins; Spleen | 1992 |